Feed RMD
RM

ResMed Inc. RMD · NYSE

$238.97 -1.35% (-$3.27)

Market cap
$35.2B
Enterprise value
$34.5B
P/E
23.1x
Forward P/E
20.2x
PEG
2.6x
P/S
6.2x
P/FCF
12.2x
EV/EBITDA
16.1x
ROIC
19.1%
Gross margin
61.2%
Net margin
26.9%
Dividend yield
1.02%
Payout ratio
23.4%
Net debt/EBITDA
-0.3x
Beta
0.75
Free float
99.1%

About the company

ResMed Inc. (RMD) is an American healthcare company specializing in the development and production of devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. With a broad portfolio of products, including CPAP machines and ventilators, ResMed is one of the leading players in the medical technology market. The company is known for its focus on innovation and technological advancement, enabling it to provide high-quality and effective treatment options. ResMed also focuses on patient and healthcare provider education to improve treatment outcomes and patient quality of life. ResMed Inc. (RMD) shares could be suitable for investors looking for opportunities in the medical technology sector with an emphasis on respiratory care and innovation.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Michael J. Farrell

Employees

11,370

Headquarters

San Diego

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.